MUC5AC and Keratoconjunctivitis sicca: Our investigation demonstrates that JBP485 promotes the expression and secretion of mucin and aqueous tear, but using a proper animal model that simulates dry eye conditions is an important next step for the evaluation of future therapeutic treatments of dry eye diseases.